Gene · 6607
Papers3,510
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,281 to 1,300 of 3,510
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Therapeutic Modulation of RNA Splicing in Malignant and Non-Malignant Disease. | Trends Mol Med | 2021 | 33994320 | PubTator, text mining | PubMed |
| Increased systemic HSP70B levels in spinal muscular atrophy infants. | Ann Clin Transl Neurol | 2021 | 33991176 | PubTator, text mining | PubMed |
| Urine-derived induced pluripotent/neural stem cells for modeling neurological diseases. | Cell Biosci | 2021 | 33985584 | PubTator, text mining | PubMed |
| Hotspot exons are common targets of splicing perturbations. | Nat Commun | 2021 | 33980843 | PubTator, text mining | PubMed |
| A high-throughput genome-wide RNAi screen identifies modifiers of survival motor neuron protein. | Cell Rep | 2021 | 33979606 | PubTator, text mining | PubMed |
| A Randomized Phase 1 Safety, Pharmacokinetic and Pharmacodynamic Study of the Novel Myostatin Inhibitor Apitegromab (SRK-015): A Potential Treatment for Spinal Muscular Atrophy. | Adv Ther | 2021 | 33963971 | PubTator, text mining | PubMed |
| The incidence of hydrocephalus among patients with and without spinal muscular atrophy (SMA): Results from a US electronic health records study. | Orphanet J Rare Dis | 2021 | 33962637 | PubTator, text mining | PubMed |
| Dual proteome-scale networks reveal cell-specific remodeling of the human interactome. | Cell | 2021 | 33961781 | PubTator, text mining | PubMed |
| Long noncoding RNAs in cancer metastasis. | Nat Rev Cancer | 2021 | 33953369 | PubTator, text mining | PubMed |
| Priority setting at the clinical level: the case of nusinersen and the Norwegian national expert group. | BMC Med Ethics | 2021 | 33947377 | PubTator, text mining | PubMed |
| [Consensus statement of the Hungarian Clinical Neurogenic Society about the therapy of adult SMA patients]. | Ideggyogy Sz | 2021 | 33938671 | PubTator, text mining | PubMed |
| The Potential of Induced Pluripotent Stem Cells to Test Gene Therapy Approaches for Neuromuscular and Motor Neuron Disorders. | Front Cell Dev Biol | 2021 | 33937264 | PubTator, text mining | PubMed |
| Tailoring NIV by dynamic laryngoscopy in a child with spinal muscular atrophy type I. | Clin Case Rep | 2021 | 33936616 | PubTator, text mining | PubMed |
| Safety, Tolerability, and Effect of Nusinersen in Non-ambulatory Adults With Spinal Muscular Atrophy. | Front Neurol | 2021 | 33935949 | PubTator, text mining | PubMed |
| The Increasing Impact of Translational Research in the Molecular Diagnostics of Neuromuscular Diseases. | Int J Mol Sci | 2021 | 33924139 | PubTator, text mining | PubMed |
| The Challenges and Strategies of Antisense Oligonucleotide Drug Delivery. | Biomedicines | 2021 | 33923688 | PubTator, text mining | PubMed |
| RNA-Binding Proteins Hold Key Roles in Function, Dysfunction, and Disease. | Biology (Basel) | 2021 | 33923168 | PubTator, text mining | PubMed |
| RNA-Targeting Splicing Modifiers: Drug Development and Screening Assays. | Molecules | 2021 | 33919699 | PubTator, text mining | PubMed |
| Utilising Induced Pluripotent Stem Cells in Neurodegenerative Disease Research: Focus on Glia. | Int J Mol Sci | 2021 | 33919317 | PubTator, text mining | PubMed |
| Nusinersen Modulates Proteomics Profiles of Cerebrospinal Fluid in Spinal Muscular Atrophy Type 1 Patients. | Int J Mol Sci | 2021 | 33919289 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6607/papers?page=65